ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Asset Performance Management (APM) Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-8I2584
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Asset Performance Management APM Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Pharmaceutical Asset Performance Management (APM) Market Insights, Forecast to 2030

Code: QYRE-Auto-8I2584
Report
July 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GE US
Rockwell Software (US)
AVEVA Group plc (UK)
Bentley Systems (US)
AspenTech (US)
Nexus Global (US)
SAP (Germany)

Pharmaceutical Asset Performance Management (APM) Market Size

The global Pharmaceutical Asset Performance Management (APM) market is projected to grow from US$ 115.3 million in 2024 to US$ 157.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.

Pharmaceutical Asset Performance Management (APM) Market

Pharmaceutical Asset Performance Management (APM) Market

Asset performance management (APM) is a proven approach to reduce unplanned downtime, decrease maintenance costs, and reduce EH&S risks.
Market Analysis and Insights: Global Pharmaceutical Asset Performance Management (APM) Market
Global Pharmaceutical Asset Performance Management (APM) key players include GE (U.S.), AVEVA Group plc (U.K.), AspenTech (U.S.), Rockwell Software (U.S.), SAP (Germany), etc. Global top five manufacturers hold a share over 65%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 35 percent.
In terms of product, APM Integrity is the largest segment, with a share over 45%.
Report Covers:
This report presents an overview of global market for Pharmaceutical Asset Performance Management (APM) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pharmaceutical Asset Performance Management (APM), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical Asset Performance Management (APM), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical Asset Performance Management (APM) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutical Asset Performance Management (APM) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutical Asset Performance Management (APM) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pharmaceutical Asset Performance Management (APM) Market Report

Report Metric Details
Report Name Pharmaceutical Asset Performance Management (APM) Market
Accounted market size in 2024 US$ 115.3 million
Forecasted market size in 2030 US$ 157.1 million
CAGR 5.3
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Asset Integrity Management
  • Asset Reliability Management
  • Other
Segment by Application
  • Large Enterprises
  • SMEs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GE (US), Rockwell Software (US), AVEVA Group plc (UK), Bentley Systems (US), AspenTech (US), Nexus Global (US), SAP (Germany)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Pharmaceutical Asset Performance Management (APM) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical Asset Performance Management (APM) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Asset Performance Management (APM) revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Pharmaceutical Asset Performance Management (APM) Market growing?

Ans: The Pharmaceutical Asset Performance Management (APM) Market witnessing a CAGR of 5.3 during the forecast period 2024-2030.

What is the Pharmaceutical Asset Performance Management (APM) Market size in 2030?

Ans: The Pharmaceutical Asset Performance Management (APM) Market size in 2030 will be US$ 157.1 million.

What is the market share of major companies in Pharmaceutical Asset Performance Management (APM) Market?

Ans: Global top five manufacturers hold a share over 65%.

Who are the main players in the Pharmaceutical Asset Performance Management (APM) Market report?

Ans: The main players in the Pharmaceutical Asset Performance Management (APM) Market are GE (US), Rockwell Software (US), AVEVA Group plc (UK), Bentley Systems (US), AspenTech (US), Nexus Global (US), SAP (Germany)

What are the Application segmentation covered in the Pharmaceutical Asset Performance Management (APM) Market report?

Ans: The Applications covered in the Pharmaceutical Asset Performance Management (APM) Market report are Large Enterprises, SMEs

What are the Type segmentation covered in the Pharmaceutical Asset Performance Management (APM) Market report?

Ans: The Types covered in the Pharmaceutical Asset Performance Management (APM) Market report are Asset Integrity Management, Asset Reliability Management, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Asset Integrity Management
1.2.3 Asset Reliability Management
1.2.4 Other
1.3 Market by Application
1.3.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Large Enterprises
1.3.3 SMEs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Asset Performance Management (APM) Market Perspective (2019-2030)
2.2 Global Pharmaceutical Asset Performance Management (APM) Growth Trends by Region
2.2.1 Pharmaceutical Asset Performance Management (APM) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Asset Performance Management (APM) Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Asset Performance Management (APM) Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Asset Performance Management (APM) Market Dynamics
2.3.1 Pharmaceutical Asset Performance Management (APM) Industry Trends
2.3.2 Pharmaceutical Asset Performance Management (APM) Market Drivers
2.3.3 Pharmaceutical Asset Performance Management (APM) Market Challenges
2.3.4 Pharmaceutical Asset Performance Management (APM) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmaceutical Asset Performance Management (APM) by Players
3.1.1 Global Pharmaceutical Asset Performance Management (APM) Revenue by Players (2019-2024)
3.1.2 Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Asset Performance Management (APM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmaceutical Asset Performance Management (APM), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pharmaceutical Asset Performance Management (APM) Market Concentration Ratio
3.4.1 Global Pharmaceutical Asset Performance Management (APM) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Asset Performance Management (APM) Revenue in 2023
3.5 Global Key Players of Pharmaceutical Asset Performance Management (APM) Head office and Area Served
3.6 Global Key Players of Pharmaceutical Asset Performance Management (APM), Product and Application
3.7 Global Key Players of Pharmaceutical Asset Performance Management (APM), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Asset Performance Management (APM) Breakdown Data by Type
4.1 Global Pharmaceutical Asset Performance Management (APM) Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Asset Performance Management (APM) Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Asset Performance Management (APM) Breakdown Data by Application
5.1 Global Pharmaceutical Asset Performance Management (APM) Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Asset Performance Management (APM) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Asset Performance Management (APM) Market Size (2019-2030)
6.2 North America Pharmaceutical Asset Performance Management (APM) Market Size by Type
6.2.1 North America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024)
6.2.2 North America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030)
6.2.3 North America Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
6.3 North America Pharmaceutical Asset Performance Management (APM) Market Size by Application
6.3.1 North America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024)
6.3.2 North America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030)
6.3.3 North America Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
6.4 North America Pharmaceutical Asset Performance Management (APM) Market Size by Country
6.4.1 North America Pharmaceutical Asset Performance Management (APM) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pharmaceutical Asset Performance Management (APM) Market Size by Country (2019-2024)
6.4.3 North America Pharmaceutical Asset Performance Management (APM) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pharmaceutical Asset Performance Management (APM) Market Size (2019-2030)
7.2 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type
7.2.1 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024)
7.2.2 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030)
7.2.3 Europe Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
7.3 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application
7.3.1 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024)
7.3.2 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030)
7.3.3 Europe Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
7.4 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Country
7.4.1 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Country (2019-2024)
7.4.3 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharmaceutical Asset Performance Management (APM) Market Size (2019-2030)
8.2 China Pharmaceutical Asset Performance Management (APM) Market Size by Type
8.2.1 China Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024)
8.2.2 China Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030)
8.2.3 China Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
8.3 China Pharmaceutical Asset Performance Management (APM) Market Size by Application
8.3.1 China Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024)
8.3.2 China Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030)
8.3.3 China Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pharmaceutical Asset Performance Management (APM) Market Size (2019-2030)
9.2 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Type
9.2.1 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024)
9.2.2 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030)
9.2.3 Asia Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
9.3 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Application
9.3.1 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024)
9.3.2 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030)
9.3.3 Asia Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
9.4 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Region
9.4.1 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Region (2019-2024)
9.4.3 Asia Pharmaceutical Asset Performance Management (APM) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GE (US)
11.1.1 GE (US) Company Details
11.1.2 GE (US) Business Overview
11.1.3 GE (US) Pharmaceutical Asset Performance Management (APM) Introduction
11.1.4 GE (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
11.1.5 GE (US) Recent Developments
11.2 Rockwell Software (US)
11.2.1 Rockwell Software (US) Company Details
11.2.2 Rockwell Software (US) Business Overview
11.2.3 Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Introduction
11.2.4 Rockwell Software (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
11.2.5 Rockwell Software (US) Recent Developments
11.3 AVEVA Group plc (UK)
11.3.1 AVEVA Group plc (UK) Company Details
11.3.2 AVEVA Group plc (UK) Business Overview
11.3.3 AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Introduction
11.3.4 AVEVA Group plc (UK) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
11.3.5 AVEVA Group plc (UK) Recent Developments
11.4 Bentley Systems (US)
11.4.1 Bentley Systems (US) Company Details
11.4.2 Bentley Systems (US) Business Overview
11.4.3 Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Introduction
11.4.4 Bentley Systems (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
11.4.5 Bentley Systems (US) Recent Developments
11.5 AspenTech (US)
11.5.1 AspenTech (US) Company Details
11.5.2 AspenTech (US) Business Overview
11.5.3 AspenTech (US) Pharmaceutical Asset Performance Management (APM) Introduction
11.5.4 AspenTech (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
11.5.5 AspenTech (US) Recent Developments
11.6 Nexus Global (US)
11.6.1 Nexus Global (US) Company Details
11.6.2 Nexus Global (US) Business Overview
11.6.3 Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Introduction
11.6.4 Nexus Global (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
11.6.5 Nexus Global (US) Recent Developments
11.7 SAP (Germany)
11.7.1 SAP (Germany) Company Details
11.7.2 SAP (Germany) Business Overview
11.7.3 SAP (Germany) Pharmaceutical Asset Performance Management (APM) Introduction
11.7.4 SAP (Germany) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
11.7.5 SAP (Germany) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
GE US
Rockwell Software (US)
AVEVA Group plc (UK)
Bentley Systems (US)
AspenTech (US)
Nexus Global (US)
SAP (Germany)
List of Tables
    Table 1. Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Asset Integrity Management
    Table 3. Key Players of Asset Reliability Management
    Table 4. Key Players of Other
    Table 5. Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Pharmaceutical Asset Performance Management (APM) Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Pharmaceutical Asset Performance Management (APM) Market Share by Region (2019-2024)
    Table 9. Global Pharmaceutical Asset Performance Management (APM) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Pharmaceutical Asset Performance Management (APM) Market Share by Region (2025-2030)
    Table 11. Pharmaceutical Asset Performance Management (APM) Market Trends
    Table 12. Pharmaceutical Asset Performance Management (APM) Market Drivers
    Table 13. Pharmaceutical Asset Performance Management (APM) Market Challenges
    Table 14. Pharmaceutical Asset Performance Management (APM) Market Restraints
    Table 15. Global Pharmaceutical Asset Performance Management (APM) Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Players (2019-2024)
    Table 17. Global Top Pharmaceutical Asset Performance Management (APM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Asset Performance Management (APM) as of 2023)
    Table 18. Global Pharmaceutical Asset Performance Management (APM) Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Pharmaceutical Asset Performance Management (APM) Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Pharmaceutical Asset Performance Management (APM), Headquarters and Area Served
    Table 21. Global Key Players of Pharmaceutical Asset Performance Management (APM), Product and Application
    Table 22. Global Key Players of Pharmaceutical Asset Performance Management (APM), Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Type (2019-2024)
    Table 26. Global Pharmaceutical Asset Performance Management (APM) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Type (2025-2030)
    Table 28. Global Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Application (2019-2024)
    Table 30. Global Pharmaceutical Asset Performance Management (APM) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Application (2025-2030)
    Table 32. North America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Pharmaceutical Asset Performance Management (APM) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Pharmaceutical Asset Performance Management (APM) Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Pharmaceutical Asset Performance Management (APM) Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Pharmaceutical Asset Performance Management (APM) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Pharmaceutical Asset Performance Management (APM) Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Pharmaceutical Asset Performance Management (APM) Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Pharmaceutical Asset Performance Management (APM) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Pharmaceutical Asset Performance Management (APM) Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Pharmaceutical Asset Performance Management (APM) Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size by Country (2025-2030) & (US$ Million)
    Table 64. GE (US) Company Details
    Table 65. GE (US) Business Overview
    Table 66. GE (US) Pharmaceutical Asset Performance Management (APM) Product
    Table 67. GE (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024) & (US$ Million)
    Table 68. GE (US) Recent Developments
    Table 69. Rockwell Software (US) Company Details
    Table 70. Rockwell Software (US) Business Overview
    Table 71. Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Product
    Table 72. Rockwell Software (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024) & (US$ Million)
    Table 73. Rockwell Software (US) Recent Developments
    Table 74. AVEVA Group plc (UK) Company Details
    Table 75. AVEVA Group plc (UK) Business Overview
    Table 76. AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Product
    Table 77. AVEVA Group plc (UK) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024) & (US$ Million)
    Table 78. AVEVA Group plc (UK) Recent Developments
    Table 79. Bentley Systems (US) Company Details
    Table 80. Bentley Systems (US) Business Overview
    Table 81. Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Product
    Table 82. Bentley Systems (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024) & (US$ Million)
    Table 83. Bentley Systems (US) Recent Developments
    Table 84. AspenTech (US) Company Details
    Table 85. AspenTech (US) Business Overview
    Table 86. AspenTech (US) Pharmaceutical Asset Performance Management (APM) Product
    Table 87. AspenTech (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024) & (US$ Million)
    Table 88. AspenTech (US) Recent Developments
    Table 89. Nexus Global (US) Company Details
    Table 90. Nexus Global (US) Business Overview
    Table 91. Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Product
    Table 92. Nexus Global (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024) & (US$ Million)
    Table 93. Nexus Global (US) Recent Developments
    Table 94. SAP (Germany) Company Details
    Table 95. SAP (Germany) Business Overview
    Table 96. SAP (Germany) Pharmaceutical Asset Performance Management (APM) Product
    Table 97. SAP (Germany) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2019-2024) & (US$ Million)
    Table 98. SAP (Germany) Recent Developments
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Pharmaceutical Asset Performance Management (APM) Market Share by Type: 2023 VS 2030
    Figure 3. Asset Integrity Management Features
    Figure 4. Asset Reliability Management Features
    Figure 5. Other Features
    Figure 6. Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Pharmaceutical Asset Performance Management (APM) Market Share by Application: 2023 VS 2030
    Figure 8. Large Enterprises Case Studies
    Figure 9. SMEs Case Studies
    Figure 10. Pharmaceutical Asset Performance Management (APM) Report Years Considered
    Figure 11. Global Pharmaceutical Asset Performance Management (APM) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Pharmaceutical Asset Performance Management (APM) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Pharmaceutical Asset Performance Management (APM) Market Share by Region: 2023 VS 2030
    Figure 14. Global Pharmaceutical Asset Performance Management (APM) Market Share by Players in 2023
    Figure 15. Global Top Pharmaceutical Asset Performance Management (APM) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Asset Performance Management (APM) as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical Asset Performance Management (APM) Revenue in 2023
    Figure 17. North America Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
    Figure 19. North America Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
    Figure 20. North America Pharmaceutical Asset Performance Management (APM) Market Share by Country (2019-2030)
    Figure 21. United States Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Pharmaceutical Asset Performance Management (APM) Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
    Figure 25. Europe Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
    Figure 26. Europe Pharmaceutical Asset Performance Management (APM) Market Share by Country (2019-2030)
    Figure 27. Germany Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Pharmaceutical Asset Performance Management (APM) Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
    Figure 35. China Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
    Figure 36. Asia Pharmaceutical Asset Performance Management (APM) Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
    Figure 38. Asia Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
    Figure 39. Asia Pharmaceutical Asset Performance Management (APM) Market Share by Region (2019-2030)
    Figure 40. Japan Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Pharmaceutical Asset Performance Management (APM) Market Share by Country (2019-2030)
    Figure 50. Brazil Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Pharmaceutical Asset Performance Management (APM) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GE (US) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
    Figure 57. Rockwell Software (US) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
    Figure 58. AVEVA Group plc (UK) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
    Figure 59. Bentley Systems (US) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
    Figure 60. AspenTech (US) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
    Figure 61. Nexus Global (US) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
    Figure 62. SAP (Germany) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2019-2024)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions